The largest community of pharma leaders

Industry News

Avalyn Pharma Reports Update in Ongoing Idiopathic Pulmonary Fibrosis Trial

SEATTLE--(BUSINESS WIRE)--Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, today announced completion of last patient...

 Janssen Receives Positive CHMP Opinion for Long-Acting Regimen for the Treatment of HIV

BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the...

Carbon Health Launches COVID Positive Care, Setting a New Standard of Care for COVID-19 Positive Patients

SAN FRANCISCO--(BUSINESS WIRE)--Carbon Health, the technology-enabled healthcare provider, has announced the launch of a specialty care program for patients who have tested positive for...

blnk Healthcare Releases New Antigen Rapid Tests

BENSHEIM, Germany--(BUSINESS WIRE)--Given the revision of numerous national testing strategies for countries within the EU, TREKSTOR is happy to announce the availability of its...

Recent Articles

ONK Therapeutics Closes New Financing and Appoints Chris Nowers as CEO

GALWAY, Ireland--(BUSINESS WIRE)--ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has raised US$8M in a financing from...

Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC 2020 Conference, on The Detailed Results From Clinical Study of TG4001 in Combination With Avelumab...

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that detailed results of...

Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment

BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotechnology today announced it has signed an agreement with Synairgen plc (LSE: SNG) for the provision of SNG001, Synairgen’s wholly-owned...

Ultimovacs Announces Updated Positive Results from Phase I Trial Evaluating Universal Cancer Vaccine, UV1, in Non-Small Cell Lung Cancer

OSLO, Norway--(BUSINESS WIRE)--Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced five-year overall survival data from the Phase I trial evaluating UV1 as maintenance therapy in...

Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech

BURLINGAME, Calif.--(BUSINESS WIRE)--Genesis Therapeutics, a privately-held company inventing and deploying state-of-the-art artificial intelligence (AI) techniques to augment drug discovery and development, today announced that...

AVEO Oncology Announces Appointment of David W. Crist as Vice President of Sales

BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the appointment of David Crist as Vice President of Sales. In this role, Mr. Crist will be...

Nimbus Therapeutics Appoints Erin Cowhig as Chief People Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the appointment of Erin Cowhig as...

SG Blocks and OSANG Healthcare Announce Managed Supply Agreement and Purchase Order to Distribute COVID-19 Rapid Test

NEW YORK--(BUSINESS WIRE)--SG Blocks, Inc. (Nasdaq: SGBX) ("SG Blocks" or the "Company"), a leader in modular container-based structures and innovator in portable, clinical-grade laboratories...

 Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer

SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion...

Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®,...

Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting 2020 show that a genomic...

Inflection Biosciences Announces Appointment of Gregory I. Berk, MD, to its Board of Directors

DUBLIN--(BUSINESS WIRE)--Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced the appointment of industry veteran Gregory I. Berk,...

Comparative Analysis of COVID-19 Reveals a Cytokine Shower, Not a Storm

MANHASSET, N.Y.--(BUSINESS WIRE)--Since coronavirus disease 2019 (COVID-19) emerged, researchers and doctors have suggested that the infection provokes a destructive immune response known as a...

Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test

LUXEMBOURG--(BUSINESS WIRE)--Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration...

Versantis Receives FDA Rare Pediatric Disease Designation for VS-01 for the Treatment of Urea Cycle Disorders

ZURICH, Switzerland--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases, today announced that the U.S. Food and Drug Administration (FDA)...